InvestorsHub Logo
Followers 113
Posts 1859
Boards Moderated 0
Alias Born 11/22/2017

Re: Hopeforthefuture3 post# 463282

Thursday, 04/28/2022 12:48:49 PM

Thursday, April 28, 2022 12:48:49 PM

Post# of 691335

Les Goldman also used to tell me that they had a higher response rate than in the Prins and Liau presentations but he was never able to point to any supporting data. I do sincerely hope the 80% is correct but for now I believe Liau.



Hopeforthefuture3,

I don't think Linda Liau ever said the response rate is between 25-30%. Here's what she said:

“The survival rate is quite remarkable compared to what would be expected for glioblastoma,” said lead author Dr. Linda Liau, chair of the neurosurgery department at the David Geffen School of Medicine at UCLA and a member of the UCLA Jonsson Comprehensive Cancer Center. “What’s particularly impressive about immunotherapy trials is that there seems to be a population of about 20 to 30 percent of patients who are living significantly longer than expected – the long tail of the survival curve. And those are the people in whom we think there may be a particularly strong immune response against their cancer that is protecting them from getting tumor reoccurrence.”


https://www.newswise.com/articles/personalized-cancer-vaccine-may-increase-long-term-survival-in-patients-with-deadly-brain-cancer?sc=mwhr&xy=10020971
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News